Base Year
Historical Year
Forecast Year
The global healthcare contract manufacturing market size was valued at USD 261.01 billion in 2023, driven by the increasing technical advancements in diagnostic tools across the globe. The market size is anticipated to grow at a CAGR of 9.4% during the forecast period of 2024-2032 to achieve a value of USD 587.83 billion by 2032.
Medical device contract manufacturing is a process where a MedTech company uses the help of drug manufacturing companies to formulate and develop their patented and authorized drugs and take care of the further process in the market. A company working for another company on their behalf due to the absence of hardware and area to perform the whole research, formulation and development and manufacturing of drugs on a contract-based relationship, is known as healthcare contract manufacturing.
There are several benefits that a MedTech company avails while in contract with the manufacturing company, such as cost-optimized manufacturing of drugs, the availability of experience and technology across various segments that can be utilized to upscale the project. The contract also provides with effective regulatory compliant manufacturing, increased access across various parts of the globe to maximize the networking and reach of the products.
Pharmaceutical contract manufacturing is the process in which pharmaceutical drugs are manufactured on a contract basis. There are several types of drugs and ways they are administered, but the most common drug delivery systems are oral, topical, and parenteral (injection).
The increased outsourcing by pharmaceutical companies and other medical companies to cut on their production expenditures and add on to the efforts and expenses on marketing of those drugs is a major key trend in the market driving the healthcare contract manufacturing market growth. The demand for more advanced formulated and personalized drug treatments are also increasing the demand.
Additionally, the increasing number of medical patients and noninvasive surgical procedures are directly increasing the demand for pharmaceutical drugs globally. To curb this increased demand, pharmaceutical companies are taking help of healthcare contract manufacturing companies.
Market Breakup by Service
Market Breakup by Type
Market Breakup by Class
Market Breakup by Type of Manufacturing
Market Breakup by End User
Market Breakup by Region
The pharmaceutical manufacturing process is evolving. The development of drugs involves years of research and testing to come up to a decision where it is confirmed that the research is through and now the manufacturing and applications may be put to use in the market. Increasing advancements in manufacturing technologies, such as continuous manufacturing, single-use technologies, and 3D printing, among others, can also potentially drive the market. The increased pressure to reduce costs and improve operational efficiency is also a significant driver for healthcare contract manufacturing market expansion.
Additionally, manufacturing safe and stable drugs is an expensive task. Hence, partnering with an industry leading CMO/CDMO gives companies new opportunities in complicated drug manufacturing market. The increasing patient population worldwide is a major driver driving the healthcare contract manufacturing market expansion as the demand for drugs manufacturing and administration is increased. Due to the low risk of product carryover and resulting market expansion, the utilization of multi product facilities to create biologics has been shown to be both economically effective and secure aiding the expansion of healthcare contract manufacturing market development.
Geographically, the North America is leading the global market due to the presence of multiple key players in the region. The growth of the market can be attributed to the developed and rapidly advancing healthcare sector in the region, along with the rising presence of the key players in the region.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Service |
|
| Breakup by Type |
|
|
Breakup by Class |
|
| Breakup by Type of Manufacturing |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 261.01 billion in 2023, driven by the rising prevalence of eye disorders.
The global market is anticipated to grow at a CAGR of 9.4% during the forecast period of 2024-2032 and reach a market value of USD 587.83 billion by 2032.
Increasing advancements in manufacturing technologies, such as continuous manufacturing and single-use technologies, among others are some of the key factors aiding the growth of the market.
The increase in outsourcing by pharmaceutical companies and other medical companies to cut on their production costs and invest it on the marketing of that drug is a major trend aiding the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa, with North America leading the global market.
The different types of services in the market include medical devices and pharmaceuticals, which are further broken into sub-categories.
The types in the market can be categorised into sterile and non-sterile.
The different classes in the market are class I, class II, and class III.
The types of manufacturing in the market are raw material, electronics, and finished goods.
The end users in the market are medical device companies, pharmaceutical companies, and biopharmaceutical companies.
Key players involved in the market are Thermo Fisher Scientific, Lonza, Celestica Inc., Integer Holdings Corporation, Nordson Corporation, Sanmina Corporation, Phillips-Medisize - a Molex Company, Catalent, Inc, Boehringer Ingelheim International GmbH, Samsung Biologics, WuXi AppTec, Cambrex Corporation, and Recifarm.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share